ADVERTISEMENT
AstraZeneca Markets an Herbal-Based Remedy to Expand in China
The company is partnering with Luye Pharma to sell a cholesterol-lowering product based on red yeast rice.
17 Jun 2019, 05:37 PM IST
(Bloomberg Businessweek) -- AstraZeneca Plc is spending big to develop cancer drugs that can sell for hundreds of thousands of dollars per patient annually. But in China, the British pharmaceutical giant is betting on a traditional heart remedy that can be bought for about $2.50 a pack. The product, an extract of a dietary supplement often used to lower cholesterol called red yeast rice, is arguably more herbal treatment than innova...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Free
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT